Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RESEARCH TOOLSreports
Holding RPID?
Track your performance easily
RPID Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.58 - $1.34
Previous Close$1.27
Volume53.47K
Average Volume (3M)72.42K
Market Cap
$54.50M
Enterprise Value-$6.33M
Total Cash (Recent Filing)$60.83M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Feb 28, 2025EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding43,034,221
10 Day Avg. Volume104,701
30 Day Avg. Volume72,415
Standard Deviation0.19
R-Squared0.08
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.64
Price to Sales (P/S)2.09
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.24
Enterprise Value/Gross Profit1.15
Enterprise Value/Ebitda0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Rapid Micro Biosystems News
PremiumCompany Announcements
Rapid Micro Biosystems Reports Strong Q3 2024 Growth
PremiumCompany Announcements
Rapid Micro Biosystems Reports Record Q3 2024 Revenue
PremiumPre-Earnings
Is RPID a Buy, Before Earnings?
Ownership Overview
26.24% Insiders
2.38% Mutual Funds
13.14% Other Institutional Investors
56.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.58 and its highest was $1.34 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Currently, no data Available
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is Feb 28, 2025 which is in 106 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Nov 01, 2024. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.255 by -$0.005.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Overvalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -$0.23.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 37,604,620 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.255. Following the earnings report the stock price went up 1.852%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Among the largest hedge funds holding Rapid Micro Biosystems’s share is Glenview Capital Management LLC. It holds Rapid Micro Biosystems’s shares valued at 793K.
---
Rapid Micro Biosystems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 117.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.65%
12-Months-Change
Fundamentals
Return on Equity
-45.62%
Trailing 12-Months
Asset Growth
-29.52%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
---
RPID Earnings Call
Q3 2024
0:00 / 0:00
---
RPID Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering RPID
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-42.60%
reiterated a buy rating 6 months ago
Copying Daniel Arias's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -42.60% per trade.
---